deferoxamine and thromboxane a2

deferoxamine has been researched along with thromboxane a2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barradas, MA; Dandona, P; Hoffbrand, AV; Jeremy, JY; Kontoghiorghes, GJ; Mikhailidis, DP1
Barry, OP; FitzGerald, GA; Ghiselli, A; Iuliano, L; Pasin, M; Praticó, D; Sabatino, G; Violi, F1

Other Studies

2 other study(ies) available for deferoxamine and thromboxane a2

ArticleYear
Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity.
    FEBS letters, 1989, Mar-13, Volume: 245, Issue:1-2

    Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Collagen; Deferiprone; Deferoxamine; Epinephrine; Humans; Iron; Iron Chelating Agents; Lipoxygenase; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Pyridones; Thromboxane A2

1989
Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C.
    Circulation, 1999, Jun-22, Volume: 99, Issue:24

    Topics: Adult; Aspirin; Blood Platelets; Catalase; Chelating Agents; Collagen; Deferoxamine; Deoxyribose; Diuretics, Osmotic; Dose-Response Relationship, Drug; Edetic Acid; Enzyme Inhibitors; Female; Humans; Hydroxyl Radical; Indoles; Iron; Isoquinolines; Male; Maleimides; Mannitol; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Sulfonamides; Thromboxane A2; Thromboxane B2

1999